Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MCK

McKesson Earnings Preview: What to Expect

McKesson is expected to unveil its fourth-quarter results next month, and analysts are projecting a double-digit profit increase.

Barchart

3 Stocks That Could Be Next to Announce a Stock Split

Stock splits often follow strong growth. Here are three high-priced stocks that could be candidates for a stock split in 2026

MarketBeat

Is Cardinal Health Stock Outperforming the Dow?

As Cardinal Health has outpaced the Dow over the past year, analysts remain bullish about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Cencora Stock Outperforming the S&P 500?

Due to Cencora's outperformance relative to the broader S&P 500 Index, Wall Street analysts remain strongly optimistic about the stock’s outlook.

Barchart

Is McKesson Corporation Stock Outperforming the Nasdaq?

McKesson shows strong relative performance, with analysts maintaining a bullish outlook on its stock.

Barchart

Is Wall Street Bullish or Bearish on McKesson Stock?

McKesson has outperformed the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.

Barchart

Stocks Sink With Alphabet, Bitcoin: Stock Market Today

A dismal round of jobs data did little to lift sentiment on Thursday.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

What You Need to Know Ahead of McKesson Corporation's Earnings Release

McKesson Corporation is ready to unveil its fiscal third-quarter earnings next month, and analysts project a double-digit profit growth.

Barchart

Is McKesson Corporation Stock Outperforming the S&P 500?

McKesson has outstripped the S&P 500 Index's rally over the past year, igniting analysts’ unflinching optimism about the healthcare stock's steadfast, upward trajectory.

Barchart

Are Wall Street Analysts Bullish on McKesson Stock?

McKesson has outpaced the broader market returns over the past year, and analysts remain upbeat on MCK, noting the company’s reliable growth momentum and supportive earnings outlook.

Barchart

This ‘Strong Buy’ Healthcare Stock Just Hit New All-Time Highs

McKesson (MCK) is trading at new all-time highs and has strong technical momentum. MCK has a 100% “Buy” opinion from Barchart. Shares are up nearly 60% over the past year. Analyst sentiment is overwhelmingly positive, with multiple “Strong Buy” ratings and price targets up to $984, despite some valuation concerns....

Barchart

What to Expect From McKesson's Next Quarterly Earnings Report

McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the company’s bottom-line figure.

Barchart

The Saturday Spread: Picking Out Empirically Intriguing Stocks Potentially Due for a Comeback (MCK, HON, AKAM)

It’s been another eventful week in the markets. These three stocks just might add some more excitement for contrarian bulls.

Barchart

How Is McKesson's Stock Performance Compared to Other Health Care Services Stocks?

McKesson has outperformed the Health Care Services industry over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

What Are Wall Street Analysts' Target Price for McKesson Stock?

McKesson has outperformed the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.

The Guardian - US

‘Did I just save her life?’: US trucker honored as ‘angel’ for role in abduction rescue

Ron Ross called 911 after he saw a young woman running in distress while he was parked at a rest area in Tennessee

MarketBeat

More Than Yield: 5 Stocks Beating the Market and Hiking Dividends

Check out these five stocks that are beating the market in 2025 and just announced dividend increases of between 10% and 15%.

Barchart

What to Expect From McKesson's Q1 2026 Earnings Report

McKesson is all set to release its fiscal first-quarter earnings next month, and analysts project a single-digit earnings growth.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

More than 1,200 mothers and 900 children impacted by Dutch fertility scandal

The clinic admitted to using sperm from mass donors for over a decade in an ‘appalling’ case

Barchart

McKesson Stock: Is Wall Street Bullish or Bearish?

As McKesson has outpaced the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Here's What to Expect From McKesson's Next Earnings Report

McKesson is expected to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit growth.

MarketBeat

3 Safe Dividend Stocks as Investors Seek to Reset Diversification

Investors have been reminded that low growth is better than no growth; here are three dividend stocks that can provide shelter in the current storm

Barchart

Is Cencora Stock Outperforming the Nasdaq?

As Cencora has outperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

MarketBeat

3 Stocks to Consider With a Possible Recession on the Table

As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness.

Barchart

Is McKesson Stock Outperforming the Dow?

As McKesson has outperformed the Dow Jones over the past year, analysts are bullish about the stock’s prospects.

1 2 3 4 5

People

David Wheeler

32 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.